Evaluating ECG Criteria for Diagnosing Left Ventricular Hypertrophy in Anabolic-Androgenic Steroid Users

Rang Abdullah1, Astrid Bjørnebekk2, Lisa E Hauger3

  • 1University of Oslo, Oslo, Norway; ProCardio Center for Research Based Innovation, Department of Cardiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway; Anabolic Androgenic Steroid Research Group, Section for Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

JACC. Advances
|January 14, 2026
PubMed

Insights

Electrocardiography (ECG) is insufficient for detecting left ventricular hypertrophy (LVH) in anabolic-androgenic steroid (AAS) users. Echocardiography is recommended for early detection of LVH and associated cardiac dysfunction in this high-risk population.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Pharmacology

Background:

  • Anabolic-androgenic steroid (AAS) users are a high-risk cardiovascular group.
  • Left ventricular hypertrophy (LVH) is a common complication in AAS users.
  • The effectiveness of electrocardiography (ECG) for detecting LVH in this population is unknown.

Purpose of the Study:

  • To evaluate the diagnostic performance of six common ECG-LVH criteria.
  • To identify LVH using echocardiography as the reference standard in long-term AAS users.

Main Methods:

  • 100 male AAS users were studied (32 with echocardiographic LVH, 68 without).
  • Six ECG-LVH criteria were assessed for sensitivity, specificity, and predictive values.
  • Echocardiography was used as the gold standard; LV systolic function was evaluated via ejection fraction and global longitudinal strain.

Main Results:

  • AAS users with LVH showed more significant LV systolic dysfunction (lower ejection fraction, impaired global longitudinal strain).
  • Peguero-Lo Presti (sensitivity 31%, specificity 88%) and Romhilt-Estes (sensitivity 34%, specificity 85%) showed the best performance among ECG criteria.
  • Most cases of echocardiographic LVH (66-69%) were missed by ECG criteria.

Conclusions:

  • ECG is inadequate for detecting echocardiographic LVH in AAS users.
  • Routine specialist evaluations, including echocardiography, are crucial for early detection of LVH and dysfunction in long-term AAS users.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
412
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
5.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
492
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471